An ideal 3-month InBody result on semaglutide with appropriate support shows: body fat mass reduced by 24 kg, skeletal muscle mass stable or minimally changed (within 0.3 kg of baseline), visceral fat level reduced by at least 1 level, BMR within 75100 kcal of baseline, and phase angle stable or improved
This placebo-controlled study in more than 6000 subjects with T2DM and acute coronary syndrome demonstrated the cardiovascular safety of chronic exposure to lixisenatide
And if your insurance doesnt cover Ozempic, the out-of-pocket monthly cost ($349 a month for self-pay patients) may be out of the question
And that, even if [00:46:00] your Hashimoto's goes away, you know, you're done breastfeeding, you're done with your baby season, you still have that loss of function
Its because our body is saltier than plain water
This can improve liver function, aiding in detoxification and overall health